AM

Afzal Mohammed Mansuri

Director DIN 05315430
DIN 05315430 First appointment Jul 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Afzal Mohammed Mansuri

Data last updated:

Afzal Mohammed Mansuri was a Director at Haneefa Homes Private Limited (from 2012) and Director at Samir Drugs Private Limited (from 2016).

DIN 05315430
First Appointment 11 Jul 2012
Oldest Company Age 22 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Haneefa Homes Private Limited U70102MH2012PTC233270
Director11 Jul 20122012Strike Off
Samir Drugs Private Limited U24230MH2003PTC143338
Director01 Mar 20162003₹50.31 Cr (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Haneefa Homes Private Limited
Samir Drugs Private Limited
Premium access

Shareholding and investment profile for Afzal Mohammed Mansuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Afzal Mohammed Mansuri

Afzal Mohammed Mansuri was first appointed on 11 Jul 2012 as Director at Haneefa Homes Private Limited. The most recent appointment on record is 01 Mar 2016 at Samir Drugs Private Limited.

Afzal Mohammed Mansuri held 2 earlier board appointments: Haneefa Homes Private Limited (Director, from 11 Jul 2012); Samir Drugs Private Limited (Director, from 01 Mar 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available